≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Unspecified nephritic syndrome

DOID EFO Endpoint Browser PheWeb

N14_NEPHRITICNAS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — N05#
  • Hospital discharge: ICD-9 — 583
  • Hospital discharge: ICD-8 — 583
  • Cause of death: ICD-10 — N05#
  • Cause of death: ICD-9 — 583
  • Cause of death: ICD-8 — 583

2 out of 7 registries used, show all original rules.

820

4. Check minimum number of events

None

820

5. Include endpoints

None

820

6. Filter based on genotype QC (FinnGen only)

820

Control definitions (FinnGen only)

Control exclude
N14_GLOMERULAR

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
N00-N08
Name in latin
Syndroma nephriticum non specificatum

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 8239 3572 4519
Only index persons 5566 2532 3034
Unadjusted period prevalence (%)
Whole population 0.12 0.10 0.13
Only index persons 0.11 0.09 0.12
Median age at first event (years)
Whole population 45.73 49.89 41.98
Only index persons 36.87 40.89 33.51

-FinnGen-

Key figures

All Female Male
Number of individuals 820 364 456
Unadjusted period prevalence (%) 0.17 0.12 0.20
Median age at first event (years) 37.79 37.66 37.90

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
738
Matched controls
7381
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
58399
ICD-8 Finland
Nephritis, unqualified
+∞
247.2
223
*
N05.9
ICD-10 Finland
Unspecified nephritic syndrome, unspecified
+∞
188.9
173
*
5839X
ICD-9 Finland
Nephritis and nephropathy, not specified as acute or chronic, With unspecified pathological lesion in kidney
+∞
146.9
136
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
90.8
138.9
152
21
Z94.0
ICD-10 Finland
Kidney transplant status
166.8
121.4
125
9
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
94.0
121.0
132
17
A12AA04
ATC
calcium carbonate; oral
100.2
108.8
118
14
A11CC03
ATC
alfacalcidol; systemic
50.8
105.7
127
30
127
Kela drug reimbursment
Transplant complication
57.7
103.0
121
25
L04AA06
ATC
mycophenolic acid; systemic
53.9
102.6
122
27
N05.8
ICD-10 Finland
Unspecified nephritic syndrome, other
1060.2
97.3
93
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
343.1
91.0
90
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
13.7
89.3
162
148
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
93.0
88.6
97
12
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
132.7
88.2
93
8
137
Kela drug reimbursment
Uraemia requiring dialysis
189.1
82.0
84
5
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
+∞
80.7
76
*
L04AA01
ATC
[U] ciclosporin; systemic
29.7
77.4
105
41
Z49.1
ICD-10 Finland
Extracorporeal dialysis
64.7
70.4
81
14
TK800
NOMESCO Finland
Hemodialysis
29.4
68.5
93
36
L04AX01
ATC
azathioprine; systemic
10.8
65.2
132
146
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
+∞
64.5
61
*
L04AD01
ATC
ciclosporin; systemic
22.0
62.9
93
48
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
53.0
60.5
72
15
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
90.5
60.0
66
8
N18.8
ICD-10 Finland
Other chronic renal failure
16.7
59.4
97
66
B03XA02
ATC
darbepoetin alfa; parenteral
36.7
59.3
76
23
Z49.0
ICD-10 Finland
Preparatory care for dialysis
108.7
55.7
60
6
B05DA
ATC
Isotonic solutions
201.6
54.8
56
*
C03CA01
ATC
furosemide; systemic
3.7
54.6
328
1319
H02AB04
ATC
methylprednisolone; systemic
4.7
53.7
211
575
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
57.2
53.7
63
12
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
148.3
52.6
55
*
B03XA01
ATC
erythropoietin; parenteral
71.0
52.0
59
9
N18.0
ICD-10 Finland
End-stage renal disease
36.8
47.8
61
18
KA1AE
NOMESCO Finland
Kidney ultrasound examination
17.2
47.3
76
49
V03AE01
ATC
polystyrene sulfonate; oral
33.1
46.6
61
20
B05DB
ATC
Hypertonic solutions
239.2
44.4
45
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.7
44.2
170
444
Z49.2
ICD-10 Finland
Other dialysis
122.4
43.3
46
*
196
Kela drug reimbursment
Paricalcitol and cinacalcet
441.8
42.6
42
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
98.0
42.3
46
5
R80
ICD-10 Finland
Isolated proteinuria
39.8
41.5
52
14
205
Kela drug reimbursment
Chronic hypertension
3.1
39.8
295
1308
M04AA01
ATC
allopurinol; systemic
4.1
39.7
175
516
7151
FHL
Kidney transplantation
408.1
39.5
39
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.1
38.9
171
503
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.3
38.5
109
198
H05BX01
ATC
cinacalcet; oral
140.7
38.1
40
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.2
37.5
107
196
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
6.3
35.8
101
182
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
+∞
34.6
33
*
N03.8
ICD-10 Finland
Chronic nephritic syndrome, other
+∞
34.6
33
*
58209
ICD-8 Finland
Chronic nephritis, Unspecified
+∞
33.6
32
*
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
+∞
32.5
31
*
N05.0
ICD-10 Finland
Unspecified nephritic syndrome, minor glomerular abnormality
+∞
32.5
31
*
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
91.8
32.0
35
*
5838X
ICD-9 Finland
Nephritis and nephropathy, not specified as acute or chronic, With other specified pathological lesion in kidney[NEPHRITIS INTERSTITIALIS CHRONICA ALIA DEFINITA]
+∞
31.5
30
*
V03AE02
ATC
sevelamer; oral
71.0
30.1
34
5
TK820
NOMESCO Finland
Peritoneal dialysis
161.5
29.9
31
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
29.7
282
1400
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
83.6
29.0
32
*
M05BA04
ATC
alendronic acid; oral
4.7
28.9
104
247
L01BB01
ATC
NA
150.7
27.8
29
*
C02AC05
ATC
moxonidine; oral
6.4
26.8
73
125
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
6.0
26.3
75
136
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
269.5
25.9
26
*
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
46.1
25.7
31
7
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
+∞
25.1
24
*
321
Kela drug reimbursment
Paricalcitol and cinacalcet
134.5
24.7
26
*
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
15.6
24.5
40
27
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
9.7
24.4
50
55
58099
ICD-8 Finland
Acute nephritis
+∞
24.1
23
*
58200
ICD-8 Finland
Chronic nephritis, Cum uraemia
+∞
24.1
23
*
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
69.8
24.0
27
*
P01BA02
ATC
hydroxychloroquine; oral
4.0
23.9
102
284
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
129.2
23.7
25
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.8
23.7
82
186
B07.9
ICD-10 Finland
Verruca simplex
7.4
23.1
56
81
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
+∞
23.0
22
*
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
+∞
23.0
22
*
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
123.8
22.7
24
*
C08CA02
ATC
felodipine; oral
3.7
22.6
107
326
C09AA02
ATC
enalapril; systemic
2.6
22.3
191
870
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.4
22.2
118
394
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
5.3
21.7
68
138
N17.9
ICD-10 Finland
Acute renal failure, unspecified
6.0
21.0
59
105
5828A
ICD-9 Finland
Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]
+∞
20.9
20
*
C07AB02
ATC
metoprolol; systemic
2.5
20.6
197
948
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.6
20.4
74
176
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
19.9
347
2199
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
19.9
19
*
L04AA05
ATC
[U] tacrolimus; systemic
+∞
19.9
19
*
V03AE03
ATC
lanthanum carbonate; oral
+∞
18.8
18
*
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
102.7
18.6
20
*
C02CA01
ATC
prazosin; oral
9.9
18.6
37
39
Z2446
NOMESCO Finland
Social worker
4.1
18.5
75
199
ZX120
NOMESCO Finland
Intravenous
3.3
18.4
101
342
L04AA13
ATC
leflunomide; oral
6.7
18.1
46
72
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.6
17.9
46
73
N04.2
ICD-10 Finland
Nephrotic syndrome, diffuse membranous glomerulonephritis
+∞
17.8
17
*
5838C
ICD-9 Finland
Nephritis and nephropathy, not specified as acute or chronic, With other specified pathological lesion in kidney[NEPHRITIS INTERSTITIALIS CHRONICA INFECTIOSA]
+∞
17.8
17
*
N04.0
ICD-10 Finland
Nephrotic syndrome, minor glomerular abnormality
+∞
17.8
17
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.3
17.7
95
317
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
184.2
17.6
18
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
9.9
17.6
35
37
R50.9
ICD-10 Finland
Fever, unspecified
2.7
17.2
125
510
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
17.2
134
570
C08CA01
ATC
amlodipine; oral
2.0
16.9
288
1772
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.8
16.9
119
477
78900
ICD-8 Finland
Abnormal urinary constituents of unspecified cause, Albuminuria
64.9
16.8
19
*
187
Kela drug reimbursment
MPA
+∞
16.7
16
*
N03.0
ICD-10 Finland
Chronic nephritic syndrome, minor glomerular abnormality
+∞
16.7
16
*
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
+∞
16.7
16
*
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
92.2
16.6
18
*
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
5.5
16.2
48
92
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
15.8
286
1791
5602
FHL
Internal fistula (eg Cimino)
+∞
15.7
15
*
N03.1
ICD-10 Finland
Chronic nephritic syndrome, focal and segmental glomerular lesions
+∞
15.7
15
*
A07EC01
ATC
sulfasalazine; oral, rectal
3.2
15.7
87
296
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
15.6
182
950
6112
FHL
Installation of a peritoneal dialysis or lavage catheter in an operating room
163.3
15.5
16
*
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
163.3
15.5
16
*
A02BC01
ATC
omeprazole; systemic
2.1
15.4
226
1300
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
46.0
15.1
18
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.0
15.0
93
340
H02AB06
ATC
prednisolone; systemic
1.9
15.0
354
2428
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
5.5
14.9
44
84
M10.3
ICD-10 Finland
Gout due to impairment of renal function
32.4
14.9
19
6
5829A
ICD-9 Finland
Chronic glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA NUD ,EI NEFR SDR]
+∞
14.6
14
*
N02AX02
ATC
tramadol; systemic, rectal
1.9
14.6
330
2226
H05BX02
ATC
paricalcitol; systemic
152.9
14.5
15
*
ZXD05
NOMESCO Finland
Urgent procedure
2.0
14.5
249
1520
K65.0
ICD-10 Finland
Acute peritonitis
11.7
14.4
26
23
C09CA01
ATC
losartan; oral
2.1
14.3
193
1067
RS220
NOMESCO Finland
NA
12.3
14.2
25
21
C08CA13
ATC
lercanidipine; oral
2.6
14.1
113
486
M10.9
ICD-10 Finland
Gout, unspecified
3.4
14.0
70
222
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
13.9
138
662
ZXA05
NOMESCO Finland
Left side
2.0
13.8
203
1160
N19
ICD-10 Finland
Unspecified kidney failure
4.9
13.7
45
97
H26.3
ICD-10 Finland
Drug-induced cataract
15.1
13.6
22
15
J01FF01
ATC
clindamycin; systemic
2.0
13.6
218
1285
4059B
ICD-9 Finland
Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]
+∞
13.6
13
*
A46
ICD-10 Finland
Erysipelas
2.4
13.6
124
569
C07AG02
ATC
carvedilol; oral
3.4
13.6
68
216
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
142.5
13.5
14
*
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
142.5
13.5
14
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.1
13.4
75
256
J01MA12
ATC
levofloxacin; systemic
2.2
13.3
161
847
C02EA02
ATC
NA
4.2
13.1
50
126
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.8
13.0
43
94
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
50.9
12.9
15
*
N05.2
ICD-10 Finland
Unspecified nephritic syndrome, diffuse membranous glomerulonephritis
+∞
12.5
12
*
40399
ICD-8 Finland
Hypertensive renal disease
+∞
12.5
12
*
N05.3
ICD-10 Finland
Unspecified nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
+∞
12.5
12
*
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
+∞
12.5
12
*
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
+∞
12.5
12
*
5850B
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA CUM URAEMIA]
+∞
12.5
12
*
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
+∞
12.5
12
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
12.4
70
241
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
12.4
190
1096
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.8
12.3
52
144
M01CB01
ATC
sodium aurothiomalate; parenteral
7.6
12.3
28
38
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.1
12.2
68
231
78930
ICD-8 Finland
Abnormal urinary constituents of unspecified cause, Haematuria
12.7
12.2
21
17
U14
ICPC
Kidney symptom/complaint
8.9
12.1
25
29
L01AA01
ATC
cyclophosphamide; systemic
27.2
12.1
16
6
JN4AD
NOMESCO Finland
Body CT examination
3.1
12.0
68
235
212
Kela drug reimbursment
Gout
5.8
11.9
33
59
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.4
11.8
35
68
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.6
11.7
89
370
ZXA00
NOMESCO Finland
Right side
1.9
11.7
207
1260
RD210
NOMESCO Finland
NA
7.3
11.6
27
38
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
5.8
11.6
32
57
Z3231
NOMESCO Finland
Registered nurse
1.9
11.6
209
1277
7910X
ICD-9 Finland
Nonspecific findings on examination of urine, Proteinuria[PROTEINURIA NUD]
+∞
11.5
11
*
PC6DE
NOMESCO Finland
NA
+∞
11.5
11
*
N03.5
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangiocapillary glomerulonephritis
+∞
11.5
11
*
KAS40
NOMESCO Finland
Excision of transplanted kidney
121.8
11.5
12
*
GD1AD
NOMESCO Finland
Thorax CT examination
3.9
11.4
47
128
TK810
NOMESCO Finland
Hemofiltration
15.3
11.3
18
12
M01AE01
ATC
ibuprofen; systemic, rectal
0.6
11.3
477
5645
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
13.0
11.2
19
15
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
11.1
167
950
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.6
11.0
83
344
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
4.6
11.0
37
83
N25.0
ICD-10 Finland
Renal osteodystrophy
44.0
10.9
13
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
10.9
294
2042
A41.9
ICD-10 Finland
Sepsis, unspecified
4.1
10.9
42
108
J01MA02
ATC
ciprofloxacin; systemic
1.7
10.7
285
1965
J01MA14
ATC
moxifloxacin; systemic
2.5
10.7
83
350
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
10.2
10.6
20
20
BBA50
NOMESCO Finland
Total parathyroidectomy
111.5
10.4
11
*
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
+∞
10.4
10
*
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
+∞
10.4
10
*
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
+∞
10.4
10
*
N03.2
ICD-10 Finland
Chronic nephritic syndrome, diffuse membranous glomerulonephritis
+∞
10.4
10
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
10.3
77
316
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.1
10.1
39
100
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
10.1
126
665
A02BA02
ATC
ranitidine; systemic
1.9
10.1
160
928
N28.9
ICD-10 Finland
Disorder of kidney and ureter, unspecified
26.4
9.8
13
5
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
20.3
9.8
14
7
C02DE02
ATC
NA
6.3
9.7
25
41
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.6
9.7
33
75
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.0
9.7
56
198
H02AB07
ATC
prednisone; oral
2.1
9.6
116
604
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.5
9.6
44
132
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
9.6
206
1323
R4110
NOMESCO Finland
Physiotherapy
1.8
9.5
194
1224
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
9.5
107
541
L88
ICPC
Rheumatoid/seropositive arthritis
3.7
9.5
40
112
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.0
9.4
37
97
28700
ICD-8 Finland
Purpura and other haemorrhagic conditions, Allergic purpura
101.3
9.4
10
*
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
101.3
9.4
10
*
6119
FHL
Other measure in this category
101.3
9.4
10
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
4.8
9.4
30
64
7101
FHL
Needle biopsy in the operating room
+∞
9.4
9
*
N05.1
ICD-10 Finland
Unspecified nephritic syndrome, focal and segmental glomerular lesions
+∞
9.4
9
*
N06.9
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, unspecified
+∞
9.4
9
*
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.8
9.4
60
227
WW200
NOMESCO Finland
Immunization
4.2
9.4
34
83
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.2
9.2
46
148
C07AB07
ATC
bisoprolol; oral
1.6
9.1
335
2503
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
9.0
197
1267
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
9.0
88
415
K65.9
ICD-10 Finland
Peritonitis, unspecified
18.9
9.0
13
7
M31.3
ICD-10 Finland
Wegener granulomatosis
24.3
8.9
12
5
R31
ICD-10 Finland
Unspecified haematuria
2.3
8.8
85
400
40199
ICD-8 Finland
Essential benign hypertension
6.1
8.8
23
39
WW400
NOMESCO Finland
Plasmaferesis
50.6
8.7
10
*
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
20.3
8.5
12
6
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
+∞
8.3
8
*
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
+∞
8.3
8
*
7158
FHL
Graft removal
+∞
8.3
8
*
5820A
ICD-9 Finland
Chronic glomerulonephritis, With lesion of proliferative glomerulonephritis[GLOMERULONEPHRITIS CHRONICA PROLIF,EI NEFR SDR]
+∞
8.3
8
*
79299
ICD-8 Finland
Uraemia
+∞
8.3
8
*
N03.7
ICD-10 Finland
Chronic nephritic syndrome, diffuse crescentic glomerulonephritis
+∞
8.3
8
*
5828B
ICD-9 Finland
Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,NEFR SDR]
+∞
8.3
8
*
Q87.80
ICD-10 Finland
Alport syndrome
+∞
8.3
8
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
8.3
395
3114
J01DB01
ATC
cefalexin; oral
1.7
8.3
576
5004
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
8.3
137
800
A02BC02
ATC
pantoprazole; systemic
1.6
8.3
447
3637
B01AA03
ATC
warfarin; systemic
1.8
8.2
148
893
J01DA01
ATC
[U] cefalexin; systemic
1.6
8.2
438
3548
J01FA06
ATC
roxithromycin; oral
1.6
8.1
288
2107
2740A
ICD-9 Finland
Gouty arthropathy
33.7
8.1
10
*
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
33.7
8.1
10
*
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
10.2
8.1
15
15
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
10.2
8.1
15
15
M81.9
ICD-10 Finland
Osteoporosis, unspecified
3.7
7.9
33
92
A12BA01
ATC
potassium chloride; oral
3.2
7.9
40
130
C02DE10
ATC
NA
7.9
7.9
17
22
Z3226
NOMESCO Finland
Physiotherapist
1.8
7.8
136
810
H02AB08
ATC
triamcinolone; systemic
15.2
7.7
12
8
5997A
ICD-9 Finland
Other disorders of urethra and urinary tract, Haematuria
15.2
7.7
12
8
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
45.5
7.7
9
*
PB1BC
NOMESCO Finland
Extensive angiography of upper extremity with X-ray
45.5
7.7
9
*
L04AB01
ATC
etanercept; parenteral
5.7
7.7
21
38
L04AA17
ATC
[U] adalimumab; parenteral
18.6
7.6
11
6
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.0
7.6
41
140
C08CA03
ATC
isradipine; systemic
5.5
7.6
21
39
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
7.6
76
363
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.3
7.5
69
318
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
4.3
7.5
26
62
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.6
7.4
18
28
306
Kela drug reimbursment
Erythropoietin and darbepoetin
80.9
7.4
8
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
80.9
7.4
8
*
5850A
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA SINE URAEMIA]
80.9
7.4
8
*
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
13.5
7.4
12
9
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
13.5
7.4
12
9
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
7.3
58
249
RS222
NOMESCO Finland
NA
6.9
7.3
17
25
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.3
7.3
35
110
GD1UN
NOMESCO Finland
Lung circulation SPECT
9.5
7.3
14
15
ZX108
NOMESCO Finland
Inhalation
9.5
7.3
14
15
Z99.2
ICD-10 Finland
Dependence on renal dialysis
+∞
7.3
7
*
B05D
ATC
PERITONEAL DIALYTICS
+∞
7.3
7
*
N08.5*M31.7
ICD-10 Finland
Glomerular disease states in microscopic polyangiitis
+∞
7.3
7
*
N04.80
ICD-10 Finland
Congenital nephrotic syndrome of the Finnish type
+∞
7.3
7
*
58199
ICD-8 Finland
Nephrotic syndrome
+∞
7.3
7
*
KAS96
NOMESCO Finland
Other transplantation of kidney or related procedure
+∞
7.3
7
*
N03.4
ICD-10 Finland
Chronic nephritic syndrome, diffuse endocapillary proliferative glomerulonephritis
+∞
7.3
7
*
C10AX09
ATC
ezetimibe; oral
2.1
7.3
85
434
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
7.3
62
275
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.9
7.2
28
74
N02AA05
ATC
oxycodone; systemic
1.9
7.2
102
563
NFA20
NOMESCO Finland
Exploration of hip joint or femur
30.3
7.2
9
*
TQW99
NOMESCO Finland
Other minor procedure on skin
2.9
7.1
41
145
WX203
NOMESCO Finland
Infraclavicular plexus blockade
4.1
7.1
26
65
RS221
NOMESCO Finland
NA
5.4
7.1
20
38
KBV00
NOMESCO Finland
Insertion of stent into ureter
8.9
7.1
14
16
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
5.9
6.9
18
31
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.2
6.9
34
109
204
Kela drug reimbursment
Leukemia lymphatica
3.4
6.9
31
93
9503
FHL
Tendon or tendon sheath cleansing surgery (tenosynovectomy)
13.9
6.9
11
8
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
3.5
6.9
30
88
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
6.9
144
906
M01CB03
ATC
auranofin; oral
8.4
6.8
14
17
GD2SN
NOMESCO Finland
Lung ventilation SPECT
8.4
6.8
14
17
J01CF02
ATC
cloxacillin; systemic
3.8
6.8
27
73
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.9
6.8
39
138
R11
ICD-10 Finland
Nausea and vomiting
2.4
6.8
56
244
N18.3
ICD-10 Finland
Chronic kidney disease, stage 3
40.4
6.8
8
*
K06.18
ICD-10 Finland
Another gingival hyperplasia
16.9
6.8
10
6
M13.9
ICD-10 Finland
Arthritis, unspecified
2.4
6.8
56
245
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.0
6.7
25
64
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.0
6.7
87
465
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
22.7
6.7
9
*
QDH05
NOMESCO Finland
Correction of deformity of toe nail
22.7
6.7
9
*
UJF32
NOMESCO Finland
Coloscopy
1.6
6.6
174
1166
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.9
6.6
105
605
N05AA02
ATC
levomepromazine; systemic
2.7
6.6
42
159
L05.0
ICD-10 Finland
Pilonidal cyst with abscess
10.1
6.5
12
12
NG4AA
NOMESCO Finland
Lower leg X-ray examination
3.6
6.5
27
76
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.2
6.5
32
103
WX202
NOMESCO Finland
Supraclavicular plexus blockade
5.4
6.5
18
34
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.7
6.4
26
72
4029B
ICD-9 Finland
Hypertensive heart disease, Unspecified[CUM DECOMPENSATIONE CORDIS (WHO III)]
70.4
6.4
7
*
9527
FHL
Alloarthroplasty, implant or endoprosthesis
70.4
6.4
7
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.6
6.4
220
1578
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
6.4
60
281
L04AA11
ATC
[U] etanercept; parenteral
14.5
6.4
10
7
C08DB01
ATC
diltiazem; oral
2.6
6.4
43
170
R4180
NOMESCO Finland
Podiatric therapy
6.6
6.4
15
23
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
6.3
186
1283
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
11.1
6.3
11
10
WX610
NOMESCO Finland
Patient controlled analgesia
11.1
6.3
11
10
I15.0
ICD-10 Finland
Renovascular hypertension
11.1
6.3
11
10
WX204
NOMESCO Finland
Axillary plexus blockaced
3.4
6.3
28
84
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
18.2
6.3
9
5
NCB20
NOMESCO Finland
Primary total prosthetic replacement of elbow joint
18.2
6.3
9
5
K65.8
ICD-10 Finland
Other peritonitis
18.2
6.3
9
5
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
6.3
112
670
N00.9
ICD-10 Finland
Acute nephritic syndrome, Unspecified
+∞
6.3
6
*
D638, N188
ICD-10 Finland
NA
+∞
6.3
6
*
N05
ICD-10 Finland
Unspecified nephritic syndrome
+∞
6.3
6
*
59329
ICD-8 Finland
Other diseases of kidney and ureter, Morbi renis NUD
+∞
6.3
6
*
2859A
ICD-9 Finland
Other and unspecified anaemias, Anaemia, unspecified[ANAEMIA SECUNDARIA]
+∞
6.3
6
*
N04.89
ICD-10 Finland
Nephrotic syndrome, other
+∞
6.3
6
*
305
Kela drug reimbursment
MPA
+∞
6.3
6
*
7148X
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies
+∞
6.3
6
*
5824A
ICD-9 Finland
Chronic glomerulonephritis, With lesion of rapidly progressive glomerulonephritis[CRESCENT GLOMERULONEPHRITIS ,EI NEFR SDR]
+∞
6.3
6
*
5819X
ICD-9 Finland
Nephrotic syndrome with unspecified pathological lesion in kidney
+∞
6.3
6
*
B01AB10
ATC
tinzaparin; parenteral
2.3
6.2
53
236
H65.2
ICD-10 Finland
Chronic serous otitis media
7.1
6.2
14
20
C07AG01
ATC
labetalol; systemic
7.1
6.2
14
20
M35.1
ICD-10 Finland
Other overlap syndromes
26.9
6.2
8
*
NDB60
NOMESCO Finland
Prosthetic replacement of MCP joint of finger
26.9
6.2
8
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
6.2
228
1660
4019X
ICD-9 Finland
Essential hypertension, Unspecified
3.4
6.2
28
85
R06.0
ICD-10 Finland
Dyspnoea
1.6
6.2
164
1105
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.7
6.1
151
995
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
7.8
6.1
13
17
C10AA04
ATC
fluvastatin; oral
2.1
6.1
67
336
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.7
6.1
39
147
TNC11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in elbow joint
12.6
6.1
10
8
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
6.8
6.1
14
21
ZZA00
NOMESCO Finland
Split skin graft
3.3
6.0
28
87
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
10.1
6.0
11
11
C10AA05
ATC
atorvastatin; oral
1.5
6.0
254
1906
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.0
6.0
22
56
L05.9
ICD-10 Finland
Pilonidal cyst without abscess
5.6
6.0
16
29

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020779) Urea [Moles/volume] in Serum or Plasma
304
520
8.71
184.96
20.5
6.0
mmol/l
12.2
9.3
8.59
294
488
(3026250) Tacrolimus [Mass/volume] in Blood
87
19
51.11
149.70
33.0
19.0
ug/l
6.6
6.9
0.20
80
14
(3003458) Phosphate [Moles/volume] in Serum or Plasma
335
782
6.56
147.23
21.1
4.9
mmol/l
1.1
1.0
9.31
325
719
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
251
452
7.57
142.65
10.8
3.1
ng/l
160.1
76.5
10.14
232
399
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
143
172
9.86
113.52
6.8
2.5
mg/l
1.9
1.5
2.79
136
156
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
122
123
11.48
109.99
7.6
5.3
iu/ml
249.0
232.3
0.08
26
18
(3042733) HLA Ab [Presence] in Serum
45
11
43.23
74.69
7.3
5.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
80
9
98.42
73.42
1.8
1.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
137
266
5.98
69.41
2.8
1.3
u/ml
12.4
13.9
—
9
6
(3021447) Carbon dioxide [Partial pressure] in Venous blood
207
593
4.33
65.84
11.7
3.2
kpa
5.8
5.8
0.07
199
577
(3002032) Base excess in Venous blood by calculation
206
591
4.32
65.35
11.7
3.2
mmol/l
1.1
2.1
3.17
175
471
(3004789) Transferrin [Mass/volume] in Serum or Plasma
264
917
3.77
63.75
7.5
2.1
g/l
2.1
2.3
15.07
258
846
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
252
859
3.79
62.43
7.7
2.2
%
22.0
23.6
1.25
223
741
(3022948) Iron [Moles/volume] in Serum or Plasma
274
989
3.66
62.25
7.3
2.2
umol/l
11.1
13.5
8.15
267
910
(3020682) Albumin/Creatinine [Ratio] in Urine
417
2019
3.17
57.55
10.2
3.8
mg/mmol
41.5
6.8
12.14
352
1300
(3000991) Gas panel - Venous blood
179
508
4.23
57.06
13.0
8.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
402
1914
3.16
56.99
8.2
3.1
mg/l
307.5
250.3
0.18
345
1241
(3000850) Epithelial cells [#/volume] in Urine
322
1353
3.27
56.48
7.8
2.4
e6/l
2.8
5.4
3.72
307
1187
(3009508) Creatinine [Moles/volume] in Urine
417
2038
3.13
56.28
8.3
3.0
mmol/l
6.4
7.9
15.17
399
1699
(3017817) Protein [Mass] in Urine collected for unspecified duration
57
50
12.18
55.67
5.9
2.8
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
124
277
5.10
53.25
2.4
2.0
g/l
1.6
1.6
0.08
110
243
(3024561) Albumin [Mass/volume] in Serum or Plasma
495
2740
3.04
52.18
14.3
4.6
g/l
34.0
35.6
8.25
475
2560
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
124
282
5.00
52.10
10.7
3.4
mmol/l
23.6
24.2
1.28
107
259
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
538
3143
3.07
50.95
23.8
6.5
mmol/l
1.2
1.2
1.24
482
2643
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
77
115
7.29
50.02
2.8
1.3
u/ml
124.0
105.7
1.20
16
23
(3024354) Oxygen [Partial pressure] in Venous blood
168
498
3.99
50.01
8.0
2.6
kpa
5.5
4.5
5.47
161
485
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
33
13
26.41
47.30
1.0
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
56
61
9.78
47.06
1.1
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
497
2863
2.87
46.78
18.7
5.9
mmol/l
1.2
1.2
0.43
476
2586
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
96
192
5.53
46.54
3.8
2.6
u/ml
0.3
0.4
0.30
55
103
(3030467) Casts [#/volume] in Urine by Automated count
360
1778
2.83
45.19
8.4
2.9
e6/l
0.2
0.5
4.22
308
1335
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
456
2544
2.79
45.12
3.6
2.2
nmol/l
74.5
76.2
0.74
439
2270
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
56
65
9.17
44.84
2.2
2.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
33
15
22.88
44.82
1.0
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
369
1854
2.80
44.70
15.1
3.8
ph
7.4
7.4
4.91
82
355
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
98
210
5.17
43.91
2.8
1.5
titre
446.0
155.0
—
10
8
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
76
129
6.39
43.65
3.0
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
69
107
6.95
43.21
10.0
2.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
379
1962
2.73
42.87
9.4
3.0
e6/l
30.4
96.9
1.26
343
1518
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
74
128
6.26
41.68
1.8
1.1
u/ml
336.0
286.8
0.39
46
75
(3026493) Urate [Moles/volume] in Serum or Plasma
343
1724
2.70
40.65
5.5
2.6
umol/l
388.5
7403.3
6.81
312
1493
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
74
136
5.88
39.14
1.8
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
517
3212
2.65
39.10
11.5
5.7
e9/l
0.6
0.6
1.40
487
2781
(36304419) Bacteria [Presence] in Urine
339
1721
2.65
39.04
7.7
2.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
159
533
3.46
38.80
4.3
2.8
g/l
63.2
66.7
5.57
151
480
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
154
506
3.52
38.77
3.9
2.7
ml/min/173m2
44.4
67.8
7.82
75
202
(3018095) Leukocytes [#/volume] in Urine
406
2259
2.58
38.52
10.6
3.5
e6/l
23.8
118.7
2.05
358
1631
(3006315) Basophils [#/volume] in Blood
517
3228
2.63
38.43
11.5
5.7
e9/l
0.0
0.0
2.32
488
2801
(3027945) Reticulocytes/100 erythrocytes in Blood
190
716
3.15
38.23
4.6
2.7
%
1.8
1.8
0.07
178
641
(3019198) Lymphocytes [#/volume] in Blood
523
3294
2.63
38.00
11.6
5.7
e9/l
1.8
2.0
1.85
495
2911
(3026782) Osmolality of Urine
274
1276
2.72
37.20
8.1
2.6
mosm/kgh2o
493.9
573.6
9.97
260
1092
(21494890) Protein electrophoresis panel - 24 hour Urine
49
61
8.48
37.05
2.6
2.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
523
3323
2.59
36.83
12.2
6.0
e9/l
0.2
0.2
0.29
497
2940
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
139
450
3.52
35.65
2.1
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
62
106
6.25
35.26
3.4
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
341
1807
2.52
35.07
7.6
4.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
382
2142
2.47
34.63
10.4
5.6
—
—
—
0
0
(3024471) HLA-A [Type]
27
15
18.58
33.52
1.0
1.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
150
529
3.25
33.43
4.5
2.8
e9/l
68.4
72.0
0.72
115
413
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
40
44
9.51
33.24
1.3
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
176
692
2.97
32.43
3.3
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
133
444
3.38
32.35
2.4
2.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
83
199
4.53
32.28
1.8
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
26
15
17.87
31.69
1.0
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
465
2944
2.34
30.80
12.0
5.8
%
0.6
0.7
0.88
451
2758
(3019069) Monocytes/100 leukocytes in Blood
476
3048
2.34
30.64
12.1
6.0
%
8.8
8.8
0.13
463
2869
(3012095) Magnesium [Moles/volume] in Serum or Plasma
220
1002
2.63
30.40
5.7
3.4
mmol/l
0.8
0.8
1.11
209
936
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
176
716
2.86
30.30
3.7
4.4
u/l
238.5
252.9
0.47
167
675
(3006504) Eosinophils/100 leukocytes in Blood
473
3033
2.32
30.18
11.9
5.8
%
2.8
2.9
0.31
462
2842
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
81
202
4.34
29.92
5.0
1.8
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
82
208
4.27
29.62
2.9
4.1
mg/l
91.3
80.9
0.11
64
170
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
82
208
4.27
29.62
3.0
4.1
mg/l
43.2
29.7
1.22
65
173
(3042936) Bacteria identified in Isolate by Culture
211
953
2.64
29.57
3.0
2.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
190
818
2.72
29.27
3.1
1.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
479
3116
2.29
29.14
12.0
5.9
%
25.5
27.7
4.32
467
2918
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
227
1075
2.54
28.74
5.3
2.6
e6/l
1.1
1.1
0.05
158
619
(3013650) Neutrophils [#/volume] in Blood by Automated count
542
3728
2.34
28.65
16.0
9.2
e9/l
4.4
4.1
2.39
513
3275
(3035350) Ketones [Presence] in Urine by Test strip
477
3126
2.26
28.11
8.8
3.4
estimate
0.0
0.0
0.00
113
608
(40760888) Immunoglobulin light chains.free panel - Serum
67
153
4.68
27.61
2.9
4.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
469
3072
2.23
27.41
11.5
5.7
%
59.7
57.2
4.43
456
2890
(3011648) Oxygen content in Venous blood
35
42
8.66
27.17
4.6
1.7
%
10.1
11.1
0.54
35
42
(3009261) Glucose [Presence] in Urine by Test strip
478
3164
2.23
27.10
8.8
3.4
estimate
0.0
0.0
0.50
118
590
(3021601) Nitrite [Presence] in Urine by Test strip
474
3131
2.22
26.96
11.2
4.6
estimate
0.0
0.0
0.00
120
619
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
78
205
4.10
26.83
3.0
4.0
ratio
0.9
2.0
—
6
20
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
217
1045
2.46
26.21
2.6
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
169
724
2.68
26.03
2.2
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
61
138
4.70
25.41
7.7
3.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
117
417
3.11
25.28
7.1
3.1
mmol/l
0.6
1.8
2.43
83
303
(3024928) Oxygen saturation in Venous blood
58
127
4.84
25.12
5.7
3.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
185
845
2.54
24.90
1.5
1.3
titre
591.8
440.2
0.52
44
173
(3009343) pH of Capillary blood
120
438
3.04
24.86
7.3
3.0
ph
7.4
7.4
0.62
21
50
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
121
445
3.02
24.73
7.4
3.0
kpa
5.0
5.1
1.32
113
416
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
24
19
12.98
24.68
2.5
2.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
40
65
6.42
23.83
1.3
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
42
72
6.09
23.74
1.3
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
68
180
4.03
23.12
4.7
2.2
mmol/l
22.9
24.8
2.66
62
157
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
164
732
2.55
23.02
2.3
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
435
2893
2.07
22.90
19.1
9.4
e9/l
0.0
0.0
0.16
366
2375
(3037121) Protein [Mass/volume] in Urine
80
239
3.60
22.88
7.2
3.5
g/l
1.1
0.2
1.88
64
98
(46235355) HIV 1 and 2 tests - Meaningful Use set
201
992
2.36
22.61
3.1
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
136
559
2.72
22.52
6.5
4.4
%
1.0
0.9
0.22
61
175
(3021440) Promyelocytes/100 leukocytes in Blood
130
525
2.75
22.27
6.5
4.5
%
0.1
0.1
0.46
58
156
(3011397) Hemoglobin [Presence] in Urine by Test strip
255
1402
2.19
22.06
7.5
3.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
54
126
4.52
21.63
4.9
2.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
85
276
3.32
21.34
3.1
2.0
ug/l
4.2
2.5
0.49
76
246
(3002179) Metamyelocytes/100 leukocytes in Blood
124
500
2.74
21.26
6.0
4.3
%
0.6
0.4
0.72
41
126
(3001122) Ferritin [Mass/volume] in Serum or Plasma
406
2682
2.02
21.24
6.5
2.6
ug/l
193.5
141.8
2.89
392
2460
(3037756) Immunofixation for Serum or Plasma
57
141
4.27
21.20
1.3
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
260
1461
2.14
21.12
9.0
4.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
525
3813
2.05
20.87
9.7
5.0
mmol/l
6.7
6.7
0.15
507
3568
(3026008) Bacteria identified in Urine by Culture
300
1793
2.06
20.59
4.4
3.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
273
1578
2.10
20.49
3.0
2.1
mg/l
3.2
3.0
0.53
243
1348
(3029937) Albumin [Presence] in Urine by Test strip
289
1721
2.05
19.90
10.0
3.6
estimate
0.0
0.0
0.50
106
603
(3019060) Gas panel - Arterial blood
108
420
2.81
19.78
6.8
6.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
397
2647
1.97
19.77
15.2
9.0
inr
1.2
1.3
0.16
128
792
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
67
197
3.61
19.59
1.9
1.6
iu/ml
0.0
0.0
0.51
14
34
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
59
161
3.87
19.21
1.4
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
576
4398
2.04
19.00
11.7
4.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
118
493
2.63
18.77
6.6
4.6
%
0.0
0.8
0.65
45
132
(3008152) Bicarbonate [Moles/volume] in Arterial blood
104
408
2.77
18.71
10.5
8.5
mmol/l
23.9
24.6
1.12
96
384
(3020891) Body temperature
77
257
3.20
18.44
10.4
4.8
—
—
—
0
0
(3010421) pH of Blood
60
171
3.71
18.36
10.1
3.9
ph
7.4
7.4
3.60
50
136
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
71
227
3.33
18.24
2.7
2.8
—
—
—
0
0
(3012501) Base excess in Blood by calculation
53
139
4.01
18.23
7.2
4.1
mmol/l
1.9
2.5
0.98
30
89
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
120
514
2.56
18.11
10.4
3.6
mmol/l
1.2
1.2
1.13
113
446
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
62
183
3.58
18.01
1.9
1.8
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
141
654
2.40
17.92
8.5
9.2
%
95.3
95.6
0.33
131
634
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
322
2055
1.93
17.73
3.6
2.5
u/l
56.3
57.3
0.20
315
1911
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
193
1026
2.15
17.68
6.0
2.8
e6/l
1.4
1.9
0.64
123
576
(40758558) Short blood count panel - Blood
267
1600
1.99
17.67
9.1
6.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
122
536
2.50
17.43
8.2
3.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
150
732
2.28
16.90
8.2
8.7
mmol/l
0.9
1.2
0.55
119
580
(3007853) Bacteria identified in Skin by Aerobe culture
155
767
2.26
16.90
2.9
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
106
447
2.58
16.47
2.0
1.5
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
149
733
2.26
16.44
7.7
8.7
kpa
5.0
5.1
0.69
139
703
(3027801) Oxygen [Partial pressure] in Arterial blood
149
733
2.26
16.44
7.7
8.7
kpa
11.5
12.1
0.71
138
705
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
57
170
3.53
16.30
4.4
2.4
ug/min
209.7
74.8
1.37
39
104
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
621
4996
2.01
16.02
15.7
7.6
u/l
76.7
78.5
0.63
607
4700
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94
379
2.67
15.97
1.9
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
139
673
2.28
15.90
4.6
3.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
363
2476
1.84
15.75
9.6
3.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
56
169
3.48
15.73
1.7
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
48
131
3.83
15.62
4.9
2.3
%
15.3
16.6
1.28
34
66
(3028026) IgM [Mass/volume] in Serum or Plasma
100
422
2.56
15.49
2.0
1.6
g/l
1.3
1.5
0.45
95
386
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
33
69
4.94
15.07
1.2
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
46
125
3.84
15.06
4.0
3.3
e9/l
4.7
4.2
0.60
46
125
(3015377) Calcium [Moles/volume] in Serum or Plasma
321
2131
1.83
15.03
6.7
3.3
mmol/l
2.3
2.4
3.34
301
1863
(3031040) Bacteria [#/volume] in Urine by Automated count
538
4171
1.84
15.00
8.2
4.2
e6/l
243.1
2820.5
1.21
11
70
(3002173) Hemoglobin [Mass/volume] in Arterial blood
127
608
2.29
14.87
9.0
9.7
g/l
117.6
122.6
1.69
121
589
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
47
131
3.75
14.85
5.2
3.7
%
60.9
56.7
1.28
47
131
(3033658) Prothrombin time (PT) actual/Normal
260
1623
1.88
14.77
5.9
3.7
%
95.3
90.0
2.41
254
1581
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
19
23
8.43
14.55
1.3
1.0
miu/ml
1522.7
1549.0
0.03
19
23
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
296
1943
1.82
14.20
2.5
2.1
u/l
207.0
259.9
0.31
279
1829
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
52
160
3.40
14.18
2.0
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
51
155
3.44
14.17
2.1
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
363
2547
1.76
13.79
4.6
3.6
ng/l
66.0
37.6
0.66
294
1780
(3047189) Immunofixation for 24 hour Urine
21
31
6.93
13.63
1.7
2.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
13
10
13.19
13.39
2.4
1.0
%
96.6
100.8
—
13
10
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
13
10
13.19
13.39
2.2
1.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
67
254
2.78
12.79
2.1
2.5
g/l
7.7
7.4
0.59
47
192
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
67
254
2.78
12.79
2.1
2.5
g/l
3.8
3.8
0.04
48
184
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
67
254
2.78
12.79
2.1
2.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
40
113
3.67
12.41
1.7
1.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
25
49
5.23
12.27
2.2
2.2
e9/l
0.9
1.1
0.47
15
27
(3019309) Folate [Moles/volume] in Red Blood Cells
196
1179
1.87
12.17
2.0
1.8
nmol/l
1541.7
1177.3
4.28
169
893
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
233
2.80
12.04
2.0
2.5
g/l
9.4
10.4
1.05
53
200
(3013707) Erythrocyte sedimentation rate by Westergren method
583
4774
1.77
11.99
8.3
4.0
mm/h
18.7
11.8
14.39
565
4403
(3004809) Band form neutrophils/100 leukocytes in Blood
37
102
3.75
11.89
4.3
3.5
%
0.9
1.4
0.40
30
86
(3015171) Extractable nuclear Ab [Units/volume] in Serum
62
235
2.77
11.85
1.4
1.2
u/ml
0.1
1.5
—
5
20
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
35
93
3.89
11.84
2.0
1.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
449
3435
1.68
11.78
7.3
6.3
umol/l
10.1
11.6
3.54
435
3262
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
16
7
23.27
11.60
12.9
6.4
mmol/l
4.6
7.1
—
16
7
(21494814) CD8 cells/100 lymphocytes in Specimen
15
18
8.47
11.52
2.1
1.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
76
325
2.48
11.40
7.9
3.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
35
96
3.76
11.33
1.9
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
45
148
3.16
11.05
1.6
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
61
239
2.68
10.94
2.1
2.6
g/l
3.3
3.2
0.40
47
188
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
14
17
8.36
10.64
2.1
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
78
349
2.36
10.60
1.4
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
31
82
3.89
10.57
3.3
2.5
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
22
45
5.00
10.31
2.0
2.0
%
49.6
39.4
—
5
5
(3006184) Hemoglobin [Mass/volume] in Capillary blood
42
139
3.13
10.22
4.2
2.0
g/l
121.6
131.3
1.52
37
102
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
398
3025
1.61
10.15
5.7
3.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
31
85
3.75
10.06
1.8
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
227
1500
1.71
10.01
1.8
1.5
nmol/l
19.9
20.4
0.20
211
1263
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
25
59
4.34
9.90
1.3
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
215
1405
1.72
9.85
8.9
3.7
kg/l
1.0
1.0
0.10
27
199
(3047181) Lactate [Moles/volume] in Blood
53
205
2.70
9.76
8.6
8.7
mmol/l
1.6
1.3
0.56
44
182
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
33
5.55
9.48
2.3
2.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
287
2041
1.63
9.44
3.6
2.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
36
114
3.26
9.42
2.3
1.6
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
22
49
4.59
9.35
1.4
1.1
titre
120.0
84.3
—
6
7
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
49
187
2.72
9.26
2.3
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
73
339
2.27
9.11
9.2
12.4
—
—
—
0
0
(4035726)
106
569
1.99
9.09
1.5
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
36
117
3.17
9.04
1.2
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
53
216
2.55
8.81
1.9
2.7
g/l
0.2
1.0
2.10
47
191
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
27
74
3.74
8.78
1.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
21
49
4.37
8.44
2.1
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
31
96
3.32
8.42
1.2
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
31
96
3.32
8.42
1.2
1.2
u/ml
5.7
4.0
0.15
16
31
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
87
3.42
8.27
1.8
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
132
786
1.81
8.23
1.7
1.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
12
7
17.37
8.09
3.0
1.1
ng/l
189.2
82.6
—
12
7
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
341
2607
1.53
7.83
2.1
2.0
pmol/l
96.6
94.7
0.29
197
1387
(3000475) Leukocytes [#/volume] in Synovial fluid
43
169
2.63
7.71
2.0
1.6
e6/l
16255.5
16100.3
0.01
32
123
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
293
2175
1.54
7.67
3.6
3.3
u/l
31.0
33.9
0.74
283
2061
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
58
264
2.29
7.60
1.6
2.1
u/l
35.9
39.4
0.58
53
231
(3002385) Erythrocyte distribution width [Ratio]
621
5419
1.60
7.59
38.5
17.0
%
14.1
13.7
8.32
616
5301
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
20
49
4.16
7.57
1.3
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
46
189
2.52
7.54
1.7
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
23
63
3.73
7.50
1.3
1.3
u/l
94.4
52.6
1.08
18
44
(3041096) Erythrocytes [Presence] in Urine by Automated
247
1776
1.56
7.41
8.9
3.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
32
111
2.96
7.24
2.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
22
60
3.74
7.22
1.1
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
17
38
4.55
7.20
1.1
1.9
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
48
206
2.41
7.19
1.9
2.6
g/l
36.7
37.6
0.38
42
177
(44790047)
25
75
3.41
7.15
1.8
1.6
—
—
—
0
0
(44790049)
25
75
3.41
7.15
1.8
1.6
—
—
—
0
0
(44806118)
25
75
3.41
7.15
1.8
1.6
—
—
—
0
0
(44790048)
25
75
3.41
7.15
1.8
1.6
—
—
—
0
0
(3025315) Body weight
10
5
20.22
7.14
6.1
3.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
23
5.73
7.08
2.9
4.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
34
125
2.79
6.94
1.8
1.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
12
20
6.07
6.92
1.2
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
259
1906
1.52
6.91
3.4
3.0
ng/l
4126.9
1344.9
3.38
236
1632
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
24
72
3.40
6.87
2.0
1.6
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
24
73
3.36
6.73
1.2
1.2
—
74.3
—
0
5
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
216
1547
1.54
6.47
3.3
2.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
28
97
2.95
6.37
2.1
1.7
g/l
0.6
0.8
0.41
18
72
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
16
38
4.27
6.31
1.3
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
80
442
1.90
6.30
2.4
1.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
56
272
2.14
6.30
9.7
3.5
mmol/l
23.8
24.8
1.79
51
257
(3052851) Hemolysis interference index of Serum or Plasma
41
175
2.41
6.24
5.3
3.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
131
844
1.66
6.10
30.7
23.2
inr
1.3
1.3
0.03
17
119
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
10
8
12.63
6.09
4.2
5.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
93
545
1.80
6.08
3.1
2.4
ug/l
7.1
7.5
0.06
87
484
(3004451) EKG impression Narrative
15
35
4.35
6.04
1.2
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
16
40
4.06
5.92
3.2
3.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
40
4.06
5.92
1.9
1.5
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
21
64
3.34
5.89
1.5
1.3
e6/l
495668.6
253576.5
0.26
14
48
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
36
149
2.48
5.86
1.6
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
24
80
3.06
5.84
1.6
1.4
%
61.5
60.4
0.04
15
59
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
15
36
4.23
5.84
2.1
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
20
60
3.39
5.75
3.3
3.1
%
65.7
54.0
1.35
12
44
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
17
5.94
5.64
2.2
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
176
1239
1.54
5.63
1.7
1.5
g/l
2.7
2.6
0.42
137
773
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
14
33
4.30
5.57
2.1
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
14
33
4.30
5.57
2.1
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
22
73
3.07
5.41
1.2
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
16
44
3.69
5.22
1.9
1.9
e6/l
730.1
712.6
—
10
17
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
88
531
1.74
5.22
3.3
3.0
ng/l
302.5
215.4
0.79
82
481
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
5
0
+∞
5.21
4.0
0.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
19
59
3.27
5.19
1.9
1.4
%
21.4
30.6
0.67
14
43
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
24
86
2.84
5.18
1.5
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
25
92
2.77
5.14
2.4
2.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
665
6060
1.52
5.12
7.8
5.7
mmol/mol
39.4
39.9
0.85
653
5632
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
128
2.48
5.10
1.8
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
128
2.48
5.10
1.8
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
196
1439
1.48
5.08
2.1
1.7
mg/l
1.9
1.2
1.59
158
1112
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
19
60
3.22
5.06
1.9
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
41
193
2.18
5.03
1.3
1.5
ug/g
230.0
275.9
0.81
28
113
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
463
3961
1.39
5.01
3.1
2.9
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
14
36
3.94
5.00
2.1
1.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
60
328
1.89
4.91
7.6
10.8
mmol/l
24.3
24.7
0.52
52
309
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
23
84
2.79
4.81
1.5
1.5
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
8
7
11.52
4.79
1.0
1.0
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
19
63
3.06
4.69
1.5
1.3
g/l
0.7
0.4
1.53
12
40
(3027135) IgG subclass 1 [Mass/volume] in Serum
19
63
3.06
4.69
1.5
1.3
g/l
8.9
6.8
0.72
12
42
(3028192) IgG subclass 2 [Mass/volume] in Serum
19
63
3.06
4.69
1.5
1.3
g/l
2.8
2.7
0.09
11
42
(3024522) Salmonella sp identified in Specimen by Organism specific culture
23
86
2.72
4.61
1.5
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
21
75
2.85
4.58
2.0
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
25
99
2.57
4.50
1.2
1.2
u/ml
4.7
6.6
0.25
17
40
(4062490)
19
65
2.97
4.46
1.5
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
51
273
1.93
4.46
2.7
2.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
29
124
2.39
4.46
1.5
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
32
144
2.27
4.39
1.3
1.2
e6/l
8.3
10.3
0.12
25
115
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
32
144
2.27
4.39
1.4
1.2
e6/l
180.0
885.3
0.46
25
119
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
13
35
3.76
4.38
1.2
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
35
3.76
4.38
2.1
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
26
4.27
4.36
1.0
1.2
—
—
—
0
0
(4268621)
19
66
2.92
4.35
2.1
2.2
—
—
—
0
0
(3036603) Volume of Urine
15
45
3.38
4.34
1.8
1.5
ml
1607.5
1895.7
—
8
10
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
35
165
2.17
4.31
4.2
2.6
%
209.1
194.9
0.34
35
158
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
701
6520
1.52
4.29
37.3
13.9
mg/l
24.1
24.1
0.00
631
5174
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
12
31
3.91
4.27
1.4
1.2
ratio
1.1
1.1
—
6
11
(3025468) Yersinia sp identified in Specimen by Organism specific culture
22
84
2.66
4.26
1.5
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
17
57
3.02
4.14
1.0
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
14
42
3.37
4.05
1.8
1.5
u/l
2.8
8.2
—
9
21
(3044889) 12 lead EKG panel
522
4636
1.35
4.01
4.9
3.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
180
1355
1.42
4.01
1.8
1.7
pmol/l
462.1
18230517.5
0.80
164
1130
(40761536) Microorganisms panel - Urine sediment
85
550
1.61
3.90
13.8
3.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
9
15
6.05
3.82
1.2
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
18
66
2.77
3.77
4.3
2.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
39
3.37
3.77
1.4
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
21
84
2.54
3.74
1.6
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
25
4.04
3.70
1.2
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
18
67
2.72
3.67
2.2
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
18
67
2.72
3.67
2.2
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
18
67
2.72
3.67
2.2
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
166
1250
1.41
3.67
4.9
3.8
ng/l
259.6
403.3
0.66
135
985
(3008757) Leukocyte morphology finding [Identifier] in Blood
19
73
2.64
3.66
4.2
3.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
21
85
2.51
3.65
1.6
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
20
79
2.57
3.65
1.2
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
35
3.46
3.63
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
18
68
2.68
3.58
2.1
1.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
715
6730
1.49
3.57
41.5
16.1
mmol/l
139.3
139.7
3.05
710
6557
(3019225) pH of Specimen
91
613
1.55
3.53
17.3
3.9
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
36
3.37
3.48
2.2
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
15
52
2.92
3.48
1.1
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
219
1745
1.35
3.41
1.9
1.6
mmol/l
1.5
1.4
0.55
199
1457
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
37
3.28
3.35
1.1
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
37
3.28
3.35
1.1
1.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
14
5.76
3.34
1.1
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
715
6751
1.47
3.30
42.6
16.2
mmol/l
4.1
4.0
9.17
709
6568
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
32
163
2.00
3.28
1.3
1.2
mg/l
458.2
454.3
0.03
32
151
(3044941) Cell count panel - Synovial fluid
24
109
2.24
3.28
1.6
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
10
28
3.60
3.20
1.4
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
60
376
1.64
3.16
2.0
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
32
166
1.97
3.13
1.4
1.3
miu/ml
90.8
214.4
—
6
72
(3045424) Erythrocytes [Presence] in Urine
24
112
2.18
3.09
2.0
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
8
7.54
3.06
1.7
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
8
7.54
3.06
1.7
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
8
7.54
3.06
1.7
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
12
310
0.38
3.03
1.3
1.6
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
5
5
10.05
2.98
1.0
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
105
760
1.44
2.89
2.3
2.4
ug/g
207.1
141.9
0.67
90
617
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
13
5.42
2.87
2.4
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
35
196
1.82
2.76
1.6
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
86
605
1.47
2.75
2.4
2.3
u/l
34.6
113.4
0.49
75
512
(3020961) Endomysium IgA Ab [Titer] in Serum
48
296
1.66
2.72
1.0
1.1
titre
—
77.3
—
0
7
(3014765) Yersinia sp identified in Stool by Organism specific culture
34
190
1.82
2.70
1.3
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
34
190
1.82
2.70
1.3
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
10
6.03
2.70
1.3
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
11
37
3.00
2.70
3.5
1.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
54
344
1.61
2.70
4.2
3.4
pmol/l
4.1
4.5
3.12
49
301
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
23
112
2.08
2.69
1.1
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
24
3.78
2.67
1.7
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
664
6248
1.33
2.64
5.8
4.0
mmol/l
1.4
1.3
1.98
639
5725
(42529406) Shigella sp [Presence] in Stool by Culture
34
192
1.80
2.62
1.3
1.1
—
—
—
0
0
(4198724)
9
25
3.63
2.58
1.4
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
11
5.49
2.54
1.2
2.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40
240
1.70
2.52
2.2
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
20
95
2.13
2.50
1.6
2.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
11
39
2.85
2.48
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
39
2.85
2.48
1.1
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
21
3.84
2.46
12.6
3.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
21
3.84
2.46
12.6
3.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
31
174
1.81
2.45
1.5
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
37
599
0.60
2.44
1.9
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
657
6195
1.31
2.41
29.3
12.9
ml/min/173m2
66.3
81.4
30.28
584
5111
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
12
5.03
2.40
1.7
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
12
5.03
2.40
1.0
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
14
58
2.44
2.38
1.6
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
17
4.14
2.36
4.1
8.4
—
—
—
0
0
(4034850)
36
214
1.71
2.36
14.2
9.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
482
4389
1.24
2.35
3.9
3.2
u/l
49.2
51.5
0.26
474
4119
(3044290) Cell count panel - Cerebral spinal fluid
24
126
1.93
2.33
1.1
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
138
1087
1.32
2.28
1.4
1.3
iu/ml
57.6
35.1
0.87
59
330
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
42
263
1.63
2.28
2.8
1.9
—
—
—
0
0
(3013512) EKG study
230
1938
1.26
2.26
4.5
3.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
15
66
2.30
2.25
1.6
1.5
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
15
66
2.30
2.25
1.3
1.3
mmol/l
5.9
5.9
0.01
15
59
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
61
0.00
2.24
0.0
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
106
805
1.36
2.23
1.4
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
519
4779
1.23
2.22
4.4
3.8
pmol/l
15.1
14.8
1.59
487
4326
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
22
115
1.94
2.17
1.8
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
14
61
2.32
2.15
1.6
1.3
e6/l
6440.7
121369.8
—
9
33
(3016650) Hepatitis A virus Ab [Presence] in Serum
23
123
1.90
2.13
1.1
1.1
—
—
—
0
0
(4027681)
11
43
2.58
2.10
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
25
3.22
2.10
1.1
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
10
5.02
2.07
1.0
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
211
1777
1.25
2.07
1.5
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
29
169
1.74
2.06
1.2
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
56
2.34
2.05
7.6
3.8
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
15
4.02
2.04
3.2
1.9
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
15
70
2.16
1.99
3.7
3.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
15
70
2.16
1.99
1.1
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
21
3.35
1.97
1.0
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
16
3.77
1.93
4.8
8.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
42
276
1.55
1.91
3.0
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
45
302
1.52
1.87
1.3
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
681
6508
1.28
1.86
6.3
4.4
mmol/l
4.4
4.6
5.62
655
6012
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
677
6467
1.27
1.84
6.2
4.4
mmol/l
1.4
1.4
0.69
652
5939
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
29
2.78
1.79
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
15
74
2.05
1.76
1.3
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
284
2507
1.20
1.74
2.4
2.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
13
3.86
1.71
4.8
9.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
96
751
1.32
1.70
2.7
2.7
umol/l
6.0
8.4
1.71
84
662
(1761868) Lipid panel - Serum or Plasma
212
2443
0.82
1.69
3.9
2.8
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
22
126
1.77
1.69
2.9
3.0
nmol/l
0.8
0.9
0.86
16
98
(4306422)
17
90
1.91
1.66
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
89
693
1.32
1.63
1.4
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
98
775
1.30
1.61
17.3
6.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
63
2.08
1.60
1.5
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
13
63
2.08
1.60
1.3
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
32
2.51
1.60
1.3
1.1
iu/ml
240.7
283.2
—
8
32
(40768443) Skin Pathology biopsy report
40
273
1.49
1.57
1.3
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
27
168
1.63
1.57
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
16
85
1.90
1.56
1.1
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
160
0.43
1.55
1.3
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
31
201
1.56
1.53
1.5
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
31
201
1.56
1.53
1.5
1.9
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
15
3.35
1.52
1.2
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
21
2.87
1.50
1.7
2.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
31
203
1.55
1.47
1.5
2.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
31
203
1.55
1.47
1.5
2.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
47
644
0.71
1.46
1.4
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
112
915
1.26
1.44
1.1
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
16
3.14
1.44
2.6
1.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
16
3.14
1.44
1.8
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
688
6630
1.24
1.43
6.6
4.9
mmol/l
2.6
2.8
7.33
665
6084
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
721
6985
1.27
1.42
21.3
10.3
u/l
24.4
27.4
6.04
715
6749
(3022621) pH of Urine by Test strip
55
407
1.38
1.42
6.1
2.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
140
1176
1.23
1.41
2.9
3.1
mmol/l
2.4
2.4
0.08
123
1034
(3051651) Icteric interference index of Serum or Plasma
9
40
2.26
1.40
10.4
3.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
25
158
1.60
1.39
1.5
1.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
125
1039
1.24
1.38
1.4
1.3
u/ml
66.8
12.1
0.60
51
410
(40761511) CBC panel - Blood by Automated count
706
6830
1.24
1.37
33.1
13.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
23
143
1.63
1.36
2.7
1.8
iu/l
3.7
6.4
—
9
46
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
47
2.14
1.34
1.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
41
0.00
1.31
0.0
1.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
24
2.51
1.30
1.2
1.5
ug/l
57.3
63.9
—
6
24
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
34
2.37
1.29
1.6
1.7
—
—
—
0
0
(44813793)
8
34
2.37
1.29
1.1
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
18
2.79
1.28
1.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
25
2.41
1.24
1.0
2.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
25
2.41
1.24
1.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
28
188
1.51
1.22
1.5
2.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
10
49
2.05
1.22
2.2
1.3
u/ml
1.5
1.1
—
5
26
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
19
2.64
1.21
1.0
1.5
umol/l
28.2
28.6
—
5
19
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
19
2.64
1.21
1.2
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
14
78
1.81
1.21
1.2
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
17
101
1.70
1.20
4.3
5.9
umol/l
331.2
379.0
0.98
17
91
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
610
5843
1.17
1.20
5.1
4.5
mu/l
2.0
2.1
0.28
587
5313
(3035880) pH of Pleural fluid
8
39
2.06
1.15
1.3
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
39
2.06
1.15
2.1
3.7
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
20
2.51
1.15
3.2
2.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
20
2.51
1.15
1.8
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
40
2.01
1.12
2.0
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
40
2.01
1.12
2.0
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
40
2.01
1.12
2.0
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
40
2.01
1.12
2.0
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
31
2.27
1.10
1.0
1.0
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
12
66
1.83
1.09
1.2
1.1
%
92.7
95.5
0.14
12
61
(3009871) Measles virus Ab [Titer] in Serum
5
21
2.39
1.09
2.0
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
89
1.70
1.08
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
29
405
0.71
1.05
1.5
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
90
1.68
1.04
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
30
213
1.42
1.03
1.6
1.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
34
2.07
1.03
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
43
326
1.34
1.01
10.9
3.6
—
—
—
0
0
(4281824)
11
61
1.81
0.98
1.4
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
36
1.95
0.97
1.1
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
77
1.70
0.95
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
138
1571
0.85
0.94
2.8
2.9
ug/l
0.7
0.7
0.18
111
1010
(3022145) Colonoscopy Study observation
88
738
1.22
0.94
1.5
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
28
2.15
0.91
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
104
0.48
0.89
1.2
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
169
0.59
0.89
1.6
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
42
1.91
0.88
1.0
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
66
799
0.81
0.88
5.6
4.5
%
32.1
31.6
0.14
57
533
(3042111) Morphology [Interpretation] in Bone marrow Narrative
17
111
1.54
0.88
1.4
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
64
1.73
0.86
1.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
31
1.94
0.84
3.5
6.7
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
46
1.75
0.82
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
46
1.75
0.82
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
46
1.75
0.82
1.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
73
1.65
0.82
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
32
1.88
0.82
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
32
1.88
0.82
1.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
13
81
1.61
0.81
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
47
1.71
0.81
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
47
1.71
0.81
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
47
1.71
0.81
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
30
225
1.35
0.79
1.8
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
96
0.52
0.78
1.2
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
53
1.71
0.75
1.1
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
53
1.71
0.75
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
53
1.71
0.75
1.0
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
25
184
1.37
0.74
7.6
4.7
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
9
55
1.64
0.73
1.1
1.0
mg/l
267.6
281.4
—
9
47
(4010399)
57
471
1.23
0.73
1.5
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
57
1.59
0.71
1.3
1.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
57
1.59
0.71
1.1
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
39
310
1.27
0.70
2.3
2.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
10
61
1.65
0.68
1.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
151
1363
1.13
0.68
1.3
1.3
u/ml
0.6
1.7
2.54
45
375
(3003740) Influenza virus B Ag [Presence] in Specimen
15
103
1.46
0.65
1.3
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
95
1.48
0.64
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
15
104
1.45
0.62
1.3
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
102
0.59
0.62
4.8
2.8
u/ml
2.9
43.8
—
6
97
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
2.4
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
2.4
1.7
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
54
1.49
0.57
1.3
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
37
1.63
0.55
1.3
1.3
nmol/l
141.0
143.9
—
6
37
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
33
268
1.24
0.53
1.6
1.9
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
39
1.54
0.53
1.2
3.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
64
1.41
0.51
1.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
86
767
1.14
0.50
1.5
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
165
0.72
0.46
1.5
1.5
—
—
—
0
0
(4024509)
7
50
1.40
0.45
1.1
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
31
1.62
0.43
2.4
1.7
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
32
1.57
0.42
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
58
1.38
0.41
1.1
1.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.0
—
23.7
—
0
15
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
2.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
20
160
1.26
0.39
1.4
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
17
134
1.27
0.37
4.0
2.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
42
1.43
0.35
1.8
2.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
18
144
1.26
0.35
1.7
1.4
nmol/l
1.1
0.9
0.47
13
121
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
25
210
1.20
0.33
1.7
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
34
294
1.16
0.33
1.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
47
1.28
0.32
1.0
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
277
2666
1.06
0.32
4.4
4.8
ug/l
2.3
2.4
0.09
262
2387
(3000492) Spirometry study
57
631
0.90
0.31
1.5
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
36
409
0.87
0.30
1.3
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
12
93
1.29
0.30
1.1
1.1
u/ml
0.4
2.2
—
5
34
(3033705) Calcium.ionized [Moles/volume] in Venous blood
12
93
1.29
0.30
2.8
2.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
26
223
1.17
0.28
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
72
1.25
0.25
1.2
1.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
9
73
1.24
0.25
1.3
1.4
pmol/l
574.8
341.7
—
9
60
(3014271) Vancomycin [Susceptibility]
5
39
1.28
0.23
2.6
2.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
79
1.27
0.22
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
604
5966
1.05
0.22
31.6
14.8
%
38.5
40.2
4.33
412
4289
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
26
229
1.14
0.22
1.8
1.8
nmol/l
37.5
40.2
0.32
26
219
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
135
1.19
0.21
1.9
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
42
1.19
0.21
1.2
2.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(44806071)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
56
519
1.08
0.20
1.4
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
16
136
1.18
0.20
1.6
2.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
111
0.81
0.20
1.4
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
19
165
1.16
0.19
1.6
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
64
599
1.07
0.19
2.1
2.2
nmol/l
14.1
13.1
0.45
58
537
(3032773) Endomysium IgG Ab [Titer] in Serum
7
62
1.13
0.17
1.0
1.0
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
7
63
1.11
0.17
1.3
1.2
nmol/l
1.8
1.5
—
7
55
(21494434) Karyotype in Bone marrow
8
68
1.18
0.16
1.0
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
71
1.13
0.16
1.0
1.2
nmol/l
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
110
1055
1.05
0.16
1.7
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
72
1.11
0.16
1.6
2.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
72
1.11
0.16
1.4
2.1
%
13.1
13.0
—
8
72
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
80
838
0.95
0.14
1.8
1.8
%
1.7
1.5
0.66
67
732
(3007461) Platelets [#/volume] in Blood
733
7294
1.05
0.13
50.9
20.4
e9/l
245.6
246.6
0.15
724
7105
(3024731) MCV [Entitic volume]
733
7297
1.04
0.11
50.5
20.3
fl
91.5
91.1
1.57
728
7189
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
95
1.16
0.11
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
28
302
0.92
0.11
1.0
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
733
7298
1.04
0.11
50.5
20.3
pg
30.2
30.4
2.07
728
7189
(3026361) Erythrocytes [#/volume] in Blood
733
7299
1.04
0.11
50.8
20.4
e12/l
4.4
4.5
11.74
723
7092
(3010813) Leukocytes [#/volume] in Blood
733
7300
1.04
0.10
50.9
20.4
e9/l
7.0
6.7
3.34
723
7091
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
154
1.11
0.10
1.3
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
733
7301
1.04
0.10
51.1
20.5
g/l
130.1
136.9
19.91
727
7189
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
60
576
1.04
0.09
1.5
1.9
—
—
—
0
0
(4094501)
17
186
0.91
0.09
1.1
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
211
2143
0.98
0.08
4.2
4.1
%
23.5
21.1
1.48
106
993
(4146454)
6
72
0.83
0.07
3.8
2.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
73
0.82
0.07
1.2
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
26
276
0.94
0.07
1.7
2.6
u/ml
53.1
51.0
0.03
26
263
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
9
100
0.90
0.06
1.0
1.1
—
15.2
—
0
6
(40768793) Breast Pathology biopsy report
12
131
0.91
0.05
1.3
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
44
426
1.03
0.05
2.6
2.8
e9/l
4.8
4.0
1.12
33
333
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
41
423
0.97
0.04
1.3
1.2
iu/ml
243.4
135.9
0.32
12
168
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
56
572
0.98
0.03
1.6
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
635
6344
1.00
0.00
5.9
4.5
mmol/l
6.0
6.0
0.01
611
5786
(36660697) Celiac disease serology panel - Serum
46
463
0.99
0.00
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
68
678
1.00
0.00
3.8
4.3
ug/l
4.6
25.5
1.09
57
566
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
10.3
—
0
5
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
11.6
—
0
5
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001729) Color of Synovial fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.1
—
75.8
—
0
9
(3016330) Potassium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
54
0.93
0.00
1.4
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
62
0.97
0.00
1.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
54
0.93
0.00
1.0
1.5
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint N14_NEPHRITICNAS and mortality.

Females

Parameter HR [95% CI] p-value
N14_NEPHRITICNAS 3.223 [2.74, 3.79] < 0.001
Birth year 0.995 [0.99, 1.0] 0.267

During the follow-up period (1.1.1998 — 31.12.2019), 526 out of 1505 females with N14_NEPHRITICNAS died.

Males

Parameter HR [95% CI] p-value
N14_NEPHRITICNAS 3.306 [2.74, 3.99] < 0.001
Birth year 0.986 [0.98, 1.0] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 460 out of 1344 males with N14_NEPHRITICNAS died.

Mortality risk

Mortality risk for people of age

years, who have N14_NEPHRITICNAS.

N-year risk Females Males
1 0.254% 0.593%
5 1.766% 3.965%
10 4.829% 9.347%
15 9.355% 16.734%
20 15.551% 27.301%

Relationships between endpoints

↥

Index endpoint: N14_NEPHRITICNAS – Unspecified nephritic syndrome

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data